Axenfeld-Rieger syndrome (ARS) and iridogoniodysgenesis syndrome (IGDS) are clinically related autosomal dominant disorders which affect the anterior segment of the eye as well as non-ocular structures. ARS patients present with iris hypoplasia, a prominent Schwalbe line, adhesions between the iris stroma and the iridocorneal angle and increased intraocular pressure. IGDS is characterized by iris hypoplasia, goniodysgenesis and increased intraocular pressure. Each syndrome also presents with non-ocular features including maxillary hypoplasia, micro and anodontia, redundant periumbilical skin, hypospadius (in males), and each has been genetically linked to chromosome 4q25. RIEG1, the gene responsible for the 4q25 ARS phenotype, recently has been cloned. RIEG1 encodes a novel member of the bicoid class of homeobox proteins known to be active as transcription factors. Mutational analysis has previously detected several mutations in this gene in ARS individuals. We have now detected a mutation in RIEG1 which segregates with the disease phenotype in a family with IGDS. This mutation is a G→A transition altering an arginine residue to a histidine in a highly conserved location in the second helix of the homeobox of RIEG1. This mutation indicates that IGDS and ARS are allelic variants of the same disorder. This wide variability in clinical consequences of mutations at the RIEG1 4q25 locus implicates the RIEG gene broadly in ocular and craniofacial disorders.
INTRODUCTION
In 1920, Axenfeld first described a patient with a prominent annular white line near the limbus at the level of the Descemet membrane (embryotoxon posterior) (1) . In 1934, Rieger described two patients with the findings noted by Axenfeld, but also observed iris stromal atrophy and congenital pupillary abnormalities (ectopia, dyscoria) (2) . Subsequently in 1935, Rieger considered the embryotoxon posterior and iris hypoplasia to be features of a single disorder that he termed dysgenesis mesodermalis corneae et iridis (3) . Some of the patients with this disorder had associated non-ocular developmental defects especially of the teeth, facial bones and periumbilical skin (4, 5) . The similarity of anterior segment angle defects described by Axenfeld and Rieger has led to the suggestion that these findings are part of a spectrum of developmental disorders (3, 6, 7) . Patients with Axenfeld-Rieger anomaly (ARA) present with the characteristic ocular features alone; the phenotype of those showing both the ocular and non-ocular features is classified as Axenfeld-Rieger syndrome (ARS) (7) . Glaucoma occurs in approximately half of ARA and ARS cases (7) .
Iridogoniodysgenesis (IGD) is an ocular abnormality also characterized by abnormalities in the differentiation of the iridocorneal angle tissue (goniodysgenesis) and maldevelopment of the anterior stromal layer of the iris associated with increased intraocular pressure resulting in juvenile glaucoma (8, 9) . Ocular findings included iris stromal hypoplasia but no excess tissue or anomalous vascularity within the angle. IGD was first recognized by Berg in 1932 as an autosomally dominant inherited disorder (10). Jerndal later re-examined and expanded Berg's pedigree and confirmed iris and iridocorneal angle defects characteristic of IGD (11) . Weatherill and Hart, in examining a different family, found iris hypoplasia and iridocorneal angle defects in 30 affected individuals (12) . These latter two studies established the slit lamp and gonioscopic features of the iris and anterior chamber angle abnormalities on which rests the current understanding of IGD. Some IGD patients also have associated non-ocular developmental defects also in the teeth, facial bones and periumbilical skin (9) . In a manner analogous to that observed in patients with Axenfeld-Rieger eye malformations, patients with iridogoniodysgenesis anomaly (IGDA) present with the characteristic ocular features alone; the phenotype seen in patients with both IGD ocular and non-ocular features is classified as iridogoniodysgenesis syndrome (IGDS). Between 75 and 100% of IGD patients develop glaucoma (12) (13) (14) (15) (16) .
IGDA and ARA have both been mapped to 6p25 (13, 17, 18) , while ARS and IGDS have been linked to 4q25 (9, 19, 20) . An additional locus for ARS has been mapped at 13q14 (21) . Recently, a gene from 4q25 has been cloned and shown to be mutated in patients with ARS (22 encodes a protein with a homeobox domain that is consistent with RIEG1 being a transcription factor. Homeobox-containing proteins have a conserved 60 amino acid DNA-binding domain and are thought to regulate gene expression during the development of multicellular organisms (23) .
We have demonstrated previously linkage of IGDS in a family to markers at 4q25 (9) . A mutation screen was therefore performed to determine if IGDS in this family was a result of a mutation in RIEG1, the gene recently found to cause ARS. Our discovery of a mutation in RIEG1 in this IGDS family shows that ARS and IGDS are allelic disorders.
RESULTS

Mutational analysis
Mutational analysis of the RIEG1 gene was initiated with published RIEG primers (22) , shown in Figure 2 . RIEG gene primers 4F/4R initially were used to amplify a portion of the RIEG gene from a patient with IGDS, but gave inconsistent results. Therefore, a new primer was designed, SK1 (Fig. 2) . A touchdown PCR reaction using primers SK1 and 4R was performed, giving a single band of ∼240 bp, the expected size of a product for this primer pair. The SK1/4R primer pair spans the majority of the RIEG1 homeodomain (Fig. 2) .
Direct sequencing of the SK1/4R PCR product from an individual affected with IGDS revealed a G→A transition (Fig.  3) . This is predicted to result in the conversion of an arginine to a histidine at the fourth residue in helix 2 of the homeodomain of RIEG1. Single strand conformation polymorphism (SSCP) analysis of the remainder of the coding region in this affected individual revealed no other alterations of the RIEG gene (data not shown).
Family analysis
SSCP analysis was carried out on the remaining affected and unaffected members of the IGDS family using primer pair SK1 and 4R to determine if this mutation segregated with the IGDS phenotype in this family. An extra band was observed in affected individuals which was absent in unaffected persons (data not shown). One hundred chromosomes from the general population were also tested by SSCP. No extra bands, or any other alterations of the SK1/4R product, were observed in the control population (data not shown).
DISCUSSION
Direct sequencing and SSCP analysis have demonstrated that patients with IGDS have a missense mutation in the fourth amino acid in helix 2 of the homeodomain of RIEG1 from the wild-type sequence of CGC (Arg70) (22) to CAC (His70). A comparison of the RIEG1 sequence with 346 known homeobox sequences reveals that this residue of helix 2 is an arginine (Arg) in 81% of homeotic gene products but has never been observed to be a histidine (His) (23) . This Arg-containing sequence is conserved in all orthodenticle class homeotic gene products (22) (Fig. 4) . The helix-turn-helix pattern seen in RIEG1 conforms to the classic homeodomain DNA-binding motif (23, 24) . The downstream helix (helix 3) is thought to fit into the major groove of DNA and establish contact with specific residues (23,24). The upstream helix (helix 2) is then thought to come into position in such a way as to make contact with phosphate residues in the backbone of DNA and stabilize the interaction of helix 3 with the DNA residues in the major groove (23) (24) (25) . The Arg70 residue mutated in the IGDS family is one of the contact points between the DNA phosphate backbone and helix 2 of homeodomain proteins (23) (24) (25) . These findings suggest that the mutation of Arg70 to a His70 in this critical region of the homeodomain of RIEG1 could destabilize the interaction of the RIEG1 protein with the target sequences of the gene(s) with which it interacts.
The discovery of a mutation in RIEG1 in a family with IGDS also demonstrates that IGDS and ARS are allelic disorders. RIEG1 mutations were identified previously in patients with ARS (22) . ARS and IGDS are characterized by ocular findings which include iris hypoplasia and increased intraocular pressure (26), and each also presents with non-ocular features including maxillary hypoplasia, missing and misshapen teeth and a failure of involution of the periumbilical skin (26) . However, patients with ARS also present with a prominent Schwalbe line and adhesions between the cornea and iris which are not present in IGDS patients (26) . Since ARS and IGDS can result from mutations in the same gene each disorder can be seen as existing along a spectrum of severity with the same underlying cause. It is tempting to speculate that the missense mutation (Arg70→His70) found in this IGDS family could result in residual function of the RIEG1 which could in turn lead to a milder eye phenotype than ARS. However, the considerable phenotypic variation observed within ARS families could preclude straightforward genotype-phenotype correlation (27) .
Data regarding the temporal and spatial expression of RIEG1 are consistent with a role in mammalian craniofacial formation (22, 28) . Mutations of the RIEG1 gene have a substantial effect upon development of the eye, teeth and jaw, suggesting that RIEG1 plays a key role in human craniofacial development. Our finding that IGDS and ARS both can result from RIEG1 mutations could implicate RIEG1 broadly in ocular and craniofacial disorders.
MATERIALS AND METHODS
Patients
The clinical features of the IGDS family have been described previously (26, 29) . The IGDS family present with autosomally dominant inheritance of IGD and somatic abnormalities (IGDS). Ocular findings include iris hypoplasia (Fig. 1a) and associated juvenile glaucoma. The anterior chamber angle is open, without excess tissue or anomalous vascularity. The somatic abnormalities in the IGDS family include maxillary hypoplasia with dental anomalies (Fig. 1b) inguinal hernia, redundant periumbilical skin and, in males, hypospadius (9, 29) . The karyotype of the IGDS family is normal (29) . The study and collection of blood samples from all individuals included in this report were approved by the Research Ethics Board of the Faculty of Medicine of the University of Alberta. Thirty nine individuals (11 affected) from the IGDS family were used previously to establish linkage of IGDS to chromosome 4q25 (9) . RIEG1, the gene underlying ARS, is located at 4q25 (22) . One affected person was chosen from the IGDS family in order to analyze the RIEG1 gene for mutations.
Genomic DNA
DNA was purified from whole blood lymphocytes using standard lysis/phenol extraction protocols. DNA was resuspended in 10 mM Tris, 1 mM EDTA pH 7.5. DNA was diluted to 5 ng/µl prior to PCR amplification.
PCR amplification
Genomic DNA was used (25 ng/PCR). Initial PCR was carried out using PCR primers 4F and 4R (22) which produced inconsistent results. Therefore, a new primer SK1 was designed (5′-ACCCGTCTAAGAAGAAGCGG-3′) (Fig. 2) . SK1/4R in a touchdown PCR program produced a single product of 240 bp. PCR conditions for SK1/4R were as follows: 95_C for 5 min, 95_C for 30 s, 55_C annealing for 30 s, 72_C for 3 s. Ten rounds of PCR were carried out in this manner, with the annealing temperature being reduced by 0.5_C/cycle to a final annealing temperature of 50_C. Thirty five subsequent rounds of PCR were carried out as follows: 95_C for 30 s, 50_C for 30 s, 72_C for 30 s, followed by a 5 min extension at 72_C. Standard PCR buffer components were obtained from Gibco BRL. A 5 µl aliquot of the PCR reaction was examined for purity and size in a 1% ethidium bromide agarose gel and observed under UV light. The remaining PCR product was purified on Qiagen columns as per instructions.
Sequencing
Purified PCR products were sequenced using the Amersham 33P Thermosequenase kit. Twenty five rounds of cycle sequencing were carried out as follows: 95_C denaturing for 30 s, 50_C annealing for 30 s and 72_C extension for 1 min. Products were separated on 6% denaturing acrylamide gels for 1.5-2 h at 60 W power and visualized by autoradiography on Kodak Biomax film.
SSCP analysis
SSCP reactions were carried out following the PCR amplification protocol above, with the addition of 5 µCi of [ 35 S]dATP (1000 µCi/ml) and a reduction of unlabeled dATP to 0.25 mM from 2 mM (30) . PCR products were separated on 6% acrylamide gels with 10% glycerol for 8 h in a 4_C cold room at 60 W prior to visualization by autoradiography.
